Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-08

Clinical Trial Update: Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating suprachoroidal injection of triamcinolone acetonide for macular edema due to non-infectious uveitis has been completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Triamcinolone Acetonide (suprachoroidal injection) (triamcinolone acetonide)

Snippet

Sponsor: Clearside Biomedical, Inc. | Conditions: Uveitis, Macular Edema | Phase 2 | Status: COMPLETED | Results posted: 2021-02-08